$KITT
Nauticus Robotics, Inc. Stock $kitt

$kitt Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022048053 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$2.982M	$0.00	$0.00
YoY Change
Cost Of Revenue	$3.781M	$2.540M	$1.899M
YoY Change	161.32%	73.58%
Gross Profit	-$799.6K	-$2.540M	-$1.899M
YoY Change	-44.74%	73.58%
Gross Profit Margin	-26.82%
Selling, General & Admin	$4.860M	$76.03K	$20.73K
YoY Change	20124.72%
% of Gross Profit
Research & Development	$243.0K	$583.9K	$1.267M
YoY Change	-67.23%	25.07%
% of Gross Profit
Depreciation & Amortization	$370.0K		$111.3K
YoY Change
% of Gross Profit
Operating Expenses	$243.0K	$1.522M	$479.4K
YoY Change	-44.88%
Operating Profit	-$6.046M	-$1.522M	-$2.688M
YoY Change	463.19%
Interest Expense	$1.402M	$739.0K	$2.431M
YoY Change	-138.75%
% of Operating Profit
Other Income/Expense, Net	-$37.84K	-$834.4K	-$816.0K
YoY Change	-90.04%	-236.8%
Pretax Income	-$13.18M	-$783.5K	$1.952M
YoY Change	196.94%
Income Tax		$12.36K
% Of Pretax Income
Net Earnings	-$6.084M	-$795.8K	$1.952M
YoY Change	37.06%
Net Earnings / Revenue	-204.04%
Basic Earnings Per Share	-$0.67	-$0.04	-$0.36
Diluted Earnings Per Share	-$0.67	-$0.04	$90.51K
COMMON SHARES
Basic Shares Outstanding	6.096M shares	21.56M shares	9.669M shares
Diluted Shares Outstanding	16.54M shares	21.56M shares	9.669M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.90M	$174.7M	$296.4K
YoY Change	4450.01%	698524.11%	1085.52%
Cash & Equivalents	$35.93M	$172.8K	$15.08M
Short-Term Investments		$174.5M
Other Short-Term Assets	$2.496M	$30.16K	$44.99K
YoY Change	327.5%
Inventory	$5.559M	$2.380M
Prepaid Expenses	$2.598M	$30.16K
Receivables	$637.4K	$1.605M
Other Receivables	$0.00
Total Short-Term Assets	$47.95M	$202.9K	$341.4K
YoY Change	3393.12%	711.77%	1265.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.646M	$6.238M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$77.89K	$174.5M	$174.2M
YoY Change	-99.96%	78524.39%	135850.67%
Total Long-Term Assets	$10.09M	$174.5M	$174.2M
YoY Change	-94.21%	78524.39%	135850.67%
TOTAL ASSETS
Total Short-Term Assets	$47.95M	$202.9K	$341.4K
Total Long-Term Assets	$10.09M	$174.5M	$174.2M
Total Assets	$58.05M	$174.7M	$174.6M
YoY Change	-66.94%	70646.07%	113884.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.787M	$325.4K	$178.3K
YoY Change	3635.81%
Accrued Expenses	$1.172M	$1.019M	$92.33K
YoY Change	644.67%	2443.0%	-28.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$400.3K	$267.0K
YoY Change		118.93%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.358M	$1.958M	$561.6K
YoY Change	1602.62%	778.36%	334.78%
LONG-TERM LIABILITIES
Long-Term Debt	$20.43M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$32.40M	$5.056M	$5.560M
YoY Change	155.71%
Total Long-Term Liabilities	$20.43M	$5.056M	$5.560M
YoY Change	61.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.358M	$1.958M	$561.6K
Total Long-Term Liabilities	$20.43M	$5.056M	$5.560M
Total Liabilities	$29.11M	$7.014M	$6.121M
YoY Change	125.22%	3046.43%	4639.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$52.79M	-$6.699M
YoY Change
Common Stock	$4.725K	$431.00
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$944.9K
YoY Change
Treasury Stock Shares		271.6K shares
Shareholders Equity	$28.93M	-$6.699M	-$5.757M
YoY Change
Total Liabilities & Shareholders Equity	$58.05M	$174.7M	$174.6M
YoY Change	-66.94%	70646.07%	113884.04%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$6.084M	-$795.8K	$1.952M
YoY Change	37.06%
Depreciation, Depletion And Amortization	$370.0K		$111.3K
YoY Change
Cash From Operating Activities	-$30.78M	-$256.9K	-$489.5K
YoY Change	3898.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$6.810M
YoY Change	-96.09%
Cash From Investing Activities	-$6.810M		-$1.675M
YoY Change	-96.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	52.92M	133.3K	267.0K
YoY Change	-69.89%
NET CHANGE
Cash From Operating Activities	-30.78M	-256.9K	-489.5K
Cash From Investing Activities	-6.810M		-$1.675M
Cash From Financing Activities	52.92M	133.3K	267.0K
Net Change In Cash	15.33M	-123.6K	-222.5K
YoY Change	1906.52%
FREE CASH FLOW
Cash From Operating Activities	-$30.78M	-$256.9K	-$489.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	325387	usd
	dei	Entity File Number EntityFileNumber	001-40611
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1699753
	dei	Entity Address Address Line1 EntityAddressAddressLine1	207 West 25th Street
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	153601	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1018979	usd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	9th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29500	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	113333	usd
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	53333	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	100000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	97200	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	400333	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1958032	usd
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	494-9005
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CLAQ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6095789	shares
CY2022Q2	us-gaap	Cash Cash	172785	usd
CY2021Q4	us-gaap	Cash Cash	518905	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	30157	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	73865	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	202942	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	592770	usd
CY2022Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	174483243	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	174230428	usd
CY2022Q2	us-gaap	Assets Assets	174686185	usd
CY2021Q4	us-gaap	Assets Assets	174823198	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	333634	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	5056000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	7973250	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7014032	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8306884	usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	17250000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	17250000	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	17250000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	17250000	shares
CY2022Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.11
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.1
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	174370884	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	174225000	usd
CY2022Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0.0001	usd
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0.0001	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4312500	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4312500	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4312500	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4312500	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	431	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	431	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6699162	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7709117	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-6698731	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-7708686	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	174686185	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	174823198	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1446459	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1905106	usd
CY2022Q2	us-gaap	Franchisor Costs FranchisorCosts	76033	usd
	us-gaap	Franchisor Costs FranchisorCosts	96761	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1522492	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2001867	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	235270	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	252815	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-503750	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2917250	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-783472	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1168198	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12359	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12359	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-795831	usd
	us-gaap	Net Income Loss NetIncomeLoss	1155839	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21562500	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3750000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21562500	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3750000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-7708686	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1951670	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5757016	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-795831	usd
CY2022Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	145884	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-6698731	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	24000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	24000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	24000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1155839	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	252815	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2917250	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-43708	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	171786	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	989479	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	60000	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2800	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-746453	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	400333	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	400333	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-346120	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	518905	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	172785	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25000	usd
	claqu	Deferred Offering Costs Included In Promissory Note Related Party DeferredOfferingCostsIncludedInPromissoryNoteRelatedParty	182856	usd
	claqu	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts	39067	usd
	claqu	Gross Proceeds GrossProceeds	675000	usd
	claqu	Percentage Of Fair Market Value PercentageOfFairMarketValue	0.80	pure
	claqu	Aggregate Of Public Shares AggregateOfPublicShares	0.20	pure
	claqu	Percentage Of Redeem Public Shares In Connection With Business Combination PercentageOfRedeemPublicSharesInConnectionWithBusinessCombination	1	pure
CY2022Q2	claqu	Public Price Per Share PublicPricePerShare	10.1
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2022Q2	claqu	Additional Share Of Common Stock AdditionalShareOfCommonStock	7500000	shares
	claqu	Merger Agreement MergerAgreement	P5Y
	us-gaap	Intercompany Agreements Description IntercompanyAgreementsDescription	one-half of the Escrow Shares will be released if, within a 5-year period following the signing date of the Merger Agreement, the volume-weighted average price of the Combined Company Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period; ii.one-quarter of the Escrow Shares will be released if, within a 5-year period following the signing date of the Merger Agreement, the volume-weighted average price of the Combined Company Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and iii.one-quarter of the Escrow Shares will be released if, within a 5-year period following the signing date of the Merger Agreement, the volume-weighted average price of the Combined Company Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period.
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	3530000	shares
CY2021Q4	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	10
CY2021Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	35300000	usd
CY2021Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	40000000	usd
CY2021Q4	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	20
CY2022Q2	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	37959184	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3036735	shares
	claqu	Aggregate Shares Reserve Equal AggregateSharesReserveEqual	0.05	pure
CY2022Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	5000001	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	50000000	usd
CY2022Q2	us-gaap	Percentage Of Weighted Average Cost Inventory PercentageOfWeightedAverageCostInventory	0.03	pure
	claqu	Business Acquisition Percentage Of Voting Interest Acquired BusinessAcquisitionPercentageOfVotingInterestAcquired	0.888	pure
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	20
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13
	claqu	Stock Issued During Period Share Other StockIssuedDuringPeriodShareOther	1000000	shares
CY2022Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	172785	usd
CY2022Q2	us-gaap	Capital Capital	1755090	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly, the actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
	claqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	17250000	shares
CY2021	claqu	Proceeds From Gross Proceeds ProceedsFromGrossProceeds	172500000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6037500	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3934879	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3672335	usd
CY2021	claqu	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	15369714	usd
CY2021	claqu	Common Stock Subject To Possible Redemptions Value CommonStockSubjectToPossibleRedemptionsValue	174225000	usd
	claqu	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	145884	usd
	claqu	Common Stock Subject To Possible Redemptions Value CommonStockSubjectToPossibleRedemptionsValue	174370884	usd
	claqu	Incurred Offering Costs IncurredOfferingCosts	3916281	usd
	claqu	Underwriting Discount Amount UnderwritingDiscountAmount	3450000	usd
	claqu	Other Offering Costs OtherOfferingCosts	466281	usd
	claqu	Offering Costs OfferingCosts	3672335	usd
	claqu	Recorded Of Offering Costs RecordedOfOfferingCosts	88910	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
	claqu	Shares Of Common Stock SharesOfCommonStock	562500	shares
	claqu	Aggregate Purchase Shares AggregatePurchaseShares	15800000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-795831	usd
	us-gaap	Net Income Loss NetIncomeLoss	1155839	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21562500	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3750000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21562500	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3750000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2021Q3	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Each Unit consists of one share of the Company’s common stock, $0.0001 par value, one right entitling the holder thereof to receive one-twentieth (1/20) of one share common stock upon the consummation of an initial business combination, and one-half of one redeemable warrant (“Redeemable Warrant”). Each whole Redeemable Warrant is exercisable to purchase one share of common stock and only whole warrants are exercisable. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Redeemable Warrants will become exercisable on the later of 30 days after the completion of the Initial Business Combination or 12 months from the closing of the Initial Public Offering. Each whole Redeemable Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50 (see Note 7).
CY2021Q3	claqu	Aggregate Purchase Price AggregatePurchasePrice	22500000	usd
	claqu	Percentage Of Gross Proceeds Of The Ipo PercentageOfGrossProceedsOfTheIPO	0.035	pure
	claqu	Common Stock At A Price Of Per Share CommonStockAtAPriceOfPerShare	11.5
	claqu	Generating Gross Proceeds GeneratingGrossProceeds	675000	usd
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1.4375-for-1 stock split of its issued and outstanding shares
	claqu	Aggregate Founder Shares AggregateFounderShares	4312500	shares
	claqu	Percentage Of Issued And Outstanding PercentageOfIssuedAndOutstanding	0.20	pure
CY2021Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2022Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
CY2021Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	0	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	0	usd
	us-gaap	Sponsor Fees SponsorFees	60000	usd
CY2021	us-gaap	Sponsor Fees SponsorFees	0	usd
CY2021Q3	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	188302	usd
CY2022Q1	claqu	Aggregate Principal Amount AggregatePrincipalAmount	267000	usd
	claqu	Promissory Note Outstanding PromissoryNoteOutstanding	267000	usd
CY2022Q2	us-gaap	Other Borrowings OtherBorrowings	133333	usd
	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	133333	usd
	us-gaap	Debt Instrument Description DebtInstrumentDescription	The notes would either be paid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of the Business Combination into additional private warrants to purchase shares of common stock at a conversion price of $1.00 per private warrant (which, for example, would result in the holders being issued private warrants to purchase 500,000 shares of common stock if $500,000 of notes were so converted).
	us-gaap	Business Combination Acquired Receivables Description BusinessCombinationAcquiredReceivablesDescription	In order to extend the time available for the Company to consummate a Business Combination, without the need for a separate stockholder vote, is for the Company’s initial stockholders or their affiliates or designees, upon five days’ advance notice prior to the application deadline, to deposit into the trust account $1,500,000 or $1,725,000 if the underwriters’ over-allotment option is exercised in full ($0.10 per public share, or an aggregate of $3,000,000 (or $3,450,000 if the over-allotment option is exercised in full) if extended for each of the full three months), on or prior to the date of the application deadline.
	claqu	Redeemable Warrants Of Shares RedeemableWarrantsOfShares	15800000	shares
CY2021	claqu	Redeemable Warrants Of Shares RedeemableWarrantsOfShares	15800000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8625000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8625000	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7175000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7175000	usd
	claqu	Number Of Shares NumberOfShares	1	shares
	claqu	Warrant Expire Term WarrantExpireTerm	P5Y
	claqu	Warrants Exercise Description WarrantsExerciseDescription	The private warrants will be identical to the public warrants underlying the units being offered by the Company’s prospectus except that (i) each private warrant is exercisable for one share of Common Stock at an exercise price of $11.50 per share, and (ii) such private warrants will be exercisable for cash (even if a registration statement covering the shares of Common Stock issuable upon exercise of such warrants is not effective) or on a cashless basis, at the holder’s option, and will not be redeemable by us, in each case so long as they are still held by the initial purchasers or their affiliates. The private warrants purchased by CleanTech Investments will not be exercisable more than five years from the effective date of the registration statement, of which the Company’s prospectus forms a part, in accordance with FINRA Rule 5110(g)(8), as long as Chardan Capital Markets, LLC or any of its related persons beneficially own these private warrants.
	claqu	Public Warrants Exercisable Description PublicWarrantsExercisableDescription	The Company may call the outstanding warrants for redemption (excluding the private warrants but including any warrants already issued upon exercise of the unit purchase option), in whole and not in part, at a price of $0.01 per warrant: ●at any time while the warrants are exercisable, ●upon not less than 30 days’ prior written notice of redemption to each warrant holder, ●if, and only if, the reported last sale price of the shares of common stock equals or exceeds $16.50 per share, for any 20 trading days within a 30-day trading period ending on the third business day prior to the notice of redemption to warrant holders, and ●if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. The right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder’s warrant upon surrender of such warrant.
	claqu	Description Of Business Combination DescriptionOfBusinessCombination	In addition, if the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at a newly issued price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Company’s initial stockholders or their affiliates, without taking into account any founder shares or private warrants held by them, as applicable, prior to such issuance), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the newly issued price and the $16.50 per share redemption trigger price described below under will be adjusted (to the nearest cent) to be equal to 165% of the market value (the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the consummation of an initial Business Combination).
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	15800000	shares
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	174483243	usd
	claqu	Warrant Liability Public Warrants WarrantLiabilityPublicWarrants	2760000	usd
	claqu	Warrant Liability Private Placement Warrants WarrantLiabilityPrivatePlacementWarrants	2296000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	174230428	usd
CY2021	claqu	Warrant Liability Public Warrants WarrantLiabilityPublicWarrants	5175000	usd
CY2021	claqu	Warrant Liability Private Placement Warrants WarrantLiabilityPrivatePlacementWarrants	2798250	usd
	claqu	Per Warrant PerWarrant	0.32
CY2021	claqu	Per Warrant PerWarrant	0.6
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	21562500	shares
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	21562500	shares
	claqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	17250000	shares
CY2021	claqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	17250000	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.016	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.011	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2022Q2	claqu	Stock Price Per Share StockPricePerShare	10.07
CY2021Q4	claqu	Stock Price Per Share StockPricePerShare	9.96
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
	claqu	Probability Of Completing A Business Combination ProbabilityOfCompletingABusinessCombination	0.38	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y7M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.112	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.087	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.03	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.012	pure
	claqu	Fair Value Of Warrants FairValueOfWarrants	0.32
CY2021	claqu	Fair Value Of Warrants FairValueOfWarrants	0.39
CY2021	claqu	Initial Measurement Of Public Warrants And Private Placement Warrants At July192021 InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrantsAtJuly192021	7980000	usd
CY2021	claqu	Initial Measurement Of Overallotment Warrants InitialMeasurementOfOverallotmentWarrants	1071000	usd
CY2021	claqu	Transfer Of Public Warrants To Level1 Measurement TransferOfPublicWarrantsToLevel1Measurement	-5175000	usd
CY2021	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	-1077750	usd
CY2021Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2798250	usd
CY2022Q1	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	-861000	usd
CY2022Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	1937250	usd
CY2022Q2	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	358750	usd
CY2022Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2296000	usd
CY2022Q2	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	503750	usd
CY2021Q2	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	2917250	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses		usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses		usd
CY2021Q2	us-gaap	Franchisor Costs FranchisorCosts		usd
	us-gaap	Franchisor Costs FranchisorCosts		usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss		usd
	us-gaap	Operating Income Loss OperatingIncomeLoss		usd
CY2021Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest		usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss		usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21562500	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21562500	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3750000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3750000	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss		usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss		usd
	us-gaap	Net Income Loss NetIncomeLoss		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent		usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities		usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities		usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
	claqu	Deferred Offering Costs Included In Promissory Note Related Party DeferredOfferingCostsIncludedInPromissoryNoteRelatedParty		usd
	claqu	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts		usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss		usd
CY2021	claqu	Probability Of Completing A Business Combination ProbabilityOfCompletingABusinessCombination		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	claqu	Discount For Lack Of Marketability DiscountForLackOfMarketability		pure
CY2021	claqu	Discount For Lack Of Marketability DiscountForLackOfMarketability		pure
CY2020Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001849820
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Net Income Loss NetIncomeLoss		usd

Files In Submission

Name	View Source	Status
0001213900-22-048053-index-headers.html	Edgar Link	pending
0001213900-22-048053-index.html	Edgar Link	pending
0001213900-22-048053.txt	Edgar Link	pending
0001213900-22-048053-xbrl.zip	Edgar Link	pending
claqu-20220630.xsd	Edgar Link	pending
f10q0622ex31-1_cleantechacq.htm	Edgar Link	pending
f10q0622ex31-2_cleantechacq.htm	Edgar Link	pending
f10q0622ex32-1_cleantechacq.htm	Edgar Link	pending
f10q0622ex32-2_cleantechacq.htm	Edgar Link	pending
f10q0622_cleantechacq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
claqu-20220630_cal.xml	Edgar Link	unprocessable
claqu-20220630_def.xml	Edgar Link	unprocessable
claqu-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
claqu-20220630_pre.xml	Edgar Link	unprocessable
f10q0622_cleantechacq_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITT
Nauticus Robotics, Inc. Stock $kitt

2022 Q3 Form 10-Q Financial Statement

#000121390022048053 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT Nauticus Robotics, Inc. Stock $kitt

2022 Q3 Form 10-Q Financial Statement

#000121390022048053 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT
Nauticus Robotics, Inc. Stock $kitt